• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:冯炎林,田伟强,蒋晓梅.UPLC-MS/MS检测大鼠体内达卢生坦的血药浓度及其药动学研究[J].中国现代应用药学,2018,35(4):506-509.
Feng Yanlin,Tian Weiqiang,Jiang xiaomei.Study on Plasma Concentration and Pharmacokinetics of Darusentan in Rat Plasma by UPLC-MS/MS[J].Chin J Mod Appl Pharm(中国现代应用药学),2018,35(4):506-509.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2214次   下载 1338 本文二维码信息
码上扫一扫!
分享到: 微信 更多
UPLC-MS/MS检测大鼠体内达卢生坦的血药浓度及其药动学研究
冯炎林, 田伟强, 蒋晓梅
温州医科大学附属五院丽水市中心医院药学部, 浙江 丽水 323000
摘要:
目的 建立一种快速、高灵敏度和高选择性的UPLC-MS/MS用于大鼠血浆中达卢生坦的测定。方法 通过蛋白沉淀法完成血浆样品处理。通过Acquity UPLC BEH C18柱(2.1 mm×50 mm,1.7 μm)色谱柱,流动相为0.1%甲酸水-乙腈,流速为0.4 mL·min-1。采用ESI+方式检测,扫描方式为多反应离子监测方式检测。结果 达卢生坦血药浓度在0.01~2.5 μg·mL-1内线性关系良好(R2>0.999 6),定量下限(LLOQ)为0.01 μg·mL-1。血浆中的达卢生坦平均回收率为87.613%~97.115%,日内及日间精密度RSD<7.71%,基质效应RSD<9.34%。结论 该方法灵敏高,快速高效,能成功应用于大鼠口服10.0 mg·kg-1达卢生坦后的药动学研究。
关键词:  达卢生坦  UPLC-MS/MS  大鼠血浆  药动学
DOI:10.13748/j.cnki.issn1007-7693.2018.04.011
分类号:R917.101
基金项目:
Study on Plasma Concentration and Pharmacokinetics of Darusentan in Rat Plasma by UPLC-MS/MS
Feng Yanlin, Tian Weiqiang, Jiang xiaomei
Department of phmarcy, the Fifth Affiliated Hospital of Wenzhou Medical University, Lishui Municipal Central Hospital, Lishui 323000, china
Abstract:
OBJECTIVE To develop a rapid, highly sensitive and selective UPLC-MS/MS for the determination of darusentan in rat plasma. METHODS Plasma samples were processed by protein precipitation. The separation was achieved by a gradient mobile phase, consisting of an aqueous solution of 0.1% formic acid and acetonitrile using an Acquity UPLC BEH C18 column (2.1 mm×50 mm, 1.7 μm). The flow rate was 0.4 mL·min-1. ESI+ was used to detect. The scanning mode was MRM. RESULTS The standard curve was linear over the range of 0.01-2.5 μg·mL-1(R2>0.999 6) with a LLOQ of 0.01 μg·mL-1. The average recovery of darusentan in plasma was 87.613%-97.115%. The RSD of intra-and inter-assay precision andaccuracy were <7.71%. The RSD of matrix effect was <9.34%. CONCLUSION This method is successfully applied in pharmacokinetic study after oral administration of 10.0 mg·kg-1 darusentan in rats.
Key words:  darusentan  UPLC-MS/MS  rat plasma  pharmacokinetic
扫一扫关注本刊微信